Clinical Trial Update: Empirical Steroids and/or Antifungals in Immunocompromised Patients With Acute Respiratory Failure From Undetermined Etiology: a Multicenter Double-blind Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial evaluating empirical steroids and/or antifungals in immunocompromised patients with acute respiratory failure of undete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunocompromised Status
• Respiratory Distress Syndrome
• Respiratory Failure

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Respiratory Failure, Immunocompromised Patients | Phase 3 | Status: UNKNOWN